- Illumina | Sequencing and array solutions to fuel genomic discoveries
Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics
- Illumina, Inc. (ILMN) - Yahoo Finance
Find the latest Illumina, Inc (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing
- Illumina, Inc. - Investors
A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments
- Illumina Knowledge | Illumina Knowledge
Illumina Knowledge is a repository of 1570 FAQs, troubleshooting articles and reference material for Illumina products and workflows, covering all Illumina Microarrays and every stage of Sequencing
- Illumina Sequencing: Principle, Steps, Uses, Diagram
Illumina sequencing allows millions of DNA fragments to be sequenced in parallel, generating vast amounts of sequencing data in a single run This makes it ideal for large-scale projects like whole-genome sequencing or transcriptome analysis
- Genomics products | Illumina
Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications
- Illumina, Inc. (NASDAQ:ILMN) Stock Position Raised by Stephens . . .
Stephens Investment Management Group LLC boosted its position in shares of Illumina, Inc (NASDAQ:ILMN - Free Report) by 22 1% during the 1st quarter, according to the company in its most recent filing with the SEC The institutional investor owned 295,597 shares of the life sciences company's stock
- Illumina to Announce Second Quarter 2025 Financial . . . - Morningstar
SAN DIEGO, July 10, 2025 PRNewswire -- Illumina, Inc (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2025 following the close of market on Thursday, July 31
|